HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 30225
 
  
 
C07D HETEROCYCLIC COMPOUNDS 14148
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
C07K PEPTIDES 7129
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 792
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 5133
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4202
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0256,542 Use of a Lipopeptide or Lipoprotein as an Adjuvant in Therapeutic or Prophylactic VaccinationsMar 22, 13Sep 08, 16[A61K]
2016/0145,304 CYSTOBACTAMIDESJul 14, 14May 26, 16[C07K]
2013/0039,939 LIPOPEPTIDE- AND LIPOPROTEIN-CONJUGATES AND ITS USEDec 12, 09Feb 14, 13[A61K, A61P, C07K]
2011/0189,142 Senescene Cells and Methods For Its ProductionJul 03, 09Aug 04, 11[A61K, C12Q, C12P, C12N, G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9597391 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositionsNov 08, 06Mar 21, 17[A61K, A61P]
9458200 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocyclesJun 23, 09Oct 04, 16[A61K, C07K]
9458200 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocyclesJun 23, 09Oct 04, 16[A61K, C07K]
9320682 and the production thereofAug 09, 13Apr 26, 16[A61K, A61C]
9217169 Synthetic pathway enzymes for the production of argyrinsFeb 27, 13Dec 22, 15[C12P, C12N, C07K]
9186381 Medicament for liver regeneration and for treatment of liver failureApr 10, 12Nov 17, 15[A61K, C12N, C07D, C07C]
8956612 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic markerJun 01, 07Feb 17, 15[A61K, C07K]
8956612 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic markerJun 01, 07Feb 17, 15[A61K, C07K]
8853249 Method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereofDec 14, 10Oct 07, 14[A61K, C07D, C07B]
8841341 Pharmaceutical composition effective against biofilmsSep 05, 08Sep 23, 14[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0203,878 PHA-PRODUCING GENETICALLY ENGINEERED MICROORGANISMSAbandonedApr 11, 13Jul 23, 15[C12P, C12N]
2014/0329,780 INHIBITOR OF COLONISATION OF MUCOSAAbandonedOct 12, 12Nov 06, 14[A61K]
2014/0256,618 Haprolid and Derivatives Thereof as Inhibitors of HCVAbandonedFeb 17, 12Sep 11, 14[C07K]
2014/0193,868 EXTRACELLULAR POLYHYDROXYALKANOATES PRODUCED BY GENETICALLY ENGINEERED MICROORGANISMSAbandonedJan 07, 14Jul 10, 14[C12P]
8623632 Extracellular polyhydroxyalkanoates produced by genetically engineered microorganismsExpiredAug 09, 06Jan 07, 14[C12N]
8530224 (Moac) and uses thereofExpiredJun 18, 09Sep 10, 13[C12Q, C12P, C12N]
8530224 (Moac) and uses thereofExpiredJun 18, 09Sep 10, 13[C12Q, C12P, C12N]
8415152 Therapeutical composition containing dentritic cells and use thereofExpiredSep 03, 10Apr 09, 13[C12N]
2013/0079,274 PHARMACEUTICAL COMPOSITIONS FOR TREATING DYSREGULATED INFLAMMATORY DISEASESAbandonedJul 30, 10Mar 28, 13[A61K, A61P]
2012/0251,579 COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSEAbandonedJul 30, 10Oct 04, 12[A61K, C12P, C07F, C12N, C07D, A61P]
2012/0244,621 TUMOR-SPECIFIC BACTERIAL PROMOTER ELEMENTSAbandonedMay 28, 10Sep 27, 12[C12N]
2012/0231,972 Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the SameAbandonedMar 19, 10Sep 13, 12[C07F, B82Y, C07D, C12N, G01N, C40B]
2012/0184,482 Novel Ubiquitin-Isopeptide ProbesAbandonedAug 19, 11Jul 19, 12[A61K, C12Q, C12N, A61P, C07K, B01D]
8003357 Acidophilic enzymesExpiredMar 03, 06Aug 23, 11[C07H, C12Q, C12P, C12N]
2011/0173,707 System for the Determination of Molecules Altering the Function of Interferon, Method Therefor and Compounds Altering Interferon ActivityAbandonedJun 26, 09Jul 14, 11[A61K, C12Q, A01K, A61P]
7977375 Antibiotic and method of production thereofExpiredSep 21, 05Jul 12, 11[A61K, C07D]
7977375 Antibiotic and method of production thereofExpiredSep 21, 05Jul 12, 11[A61K, C07D]
2011/0086,367 PHARMACEUTICALS FOR INFLUENCING THE REACTION OF THE HUMAN IMMUNE SYSTEMAbandonedApr 03, 07Apr 14, 11[C12Q, C12N, G01N, C07K]
2011/0064,769 VV PROMOTER-DRIVEN OVEREXPRESSION OF RECOMBINANT ANTIGENSAbandonedSep 26, 08Mar 17, 11[A61K, A61P]
2011/0052,579 Ligands of the Natural Killer (NK) Cell Surface Marker CD27 and Therapeutic Uses Thereof,AbandonedFeb 16, 09Mar 03, 11[A61K, C12N, G01N, A61P, C40B]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.